Abbott Laboratories
ABT | NYSE
$102.92
+$0.31 (+0.30%)
Sep 21, 2026, 2:49 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 8.52B | 7.62B | 6.9B | 9.88B | 9.8B | 6.84B |
Short-Term Investments | 417M | 351M | 383M | 288M | 450M | 310M |
Long-Term Investments | 918M | 886M | 799M | 766M | 903M | 1.03B |
Other Long-Term Assets | 17.3B | 15.38B | 5.98B | 4.92B | 3.97B | 2.42B |
Receivables | 7.93B | 6.93B | 6.57B | 6.22B | 6.49B | 6.41B |
Inventory | 6.49B | 6.19B | 6.57B | 6.17B | 5.16B | 5.01B |
Other Current Assets | 2.64B | 2.57B | 2.26B | 2.66B | 2.35B | 1.87B |
Total Current Assets | 26B | 23.66B | 22.67B | 25.22B | 24.24B | 20.44B |
Property-Plant & Equipment | 12.94B | 11.73B | 11.28B | 10.28B | 10.11B | 10.13B |
Goodwill & Intangibles | 29.56B | 29.76B | 32.49B | 33.25B | 35.97B | 38.53B |
Total Long-Term Assets | 60.72B | 57.76B | 50.54B | 49.21B | 50.96B | 52.11B |
Total Assets | 86.71B | 81.41B | 73.21B | 74.44B | 75.2B | 72.55B |
Account Payables | 4.24B | 4.2B | 4.3B | 4.61B | 4.41B | 3.95B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 3.31B | 1.75B | 1.33B | 2.48B | 999M | 461M |
Other Current Liabilities | 5.54B | 5.91B | 6.13B | 6.5B | 5.77B | 5.72B |
Total Current Liabilities | 16.5B | 14.16B | 13.84B | 15.49B | 13.11B | 11.91B |
Long-Term Debt | 10.83B | 12.63B | 13.6B | 14.52B | 17.3B | 18.53B |
Other Long-Term Liabilities | 3.73B | 4.46B | 4.78B | 4.74B | 5.74B | 6.06B |
Total Long-Term Liabilities | 17.45B | 19.36B | 20.55B | 22.04B | 26.07B | 27.64B |
Total Liabilities | 33.94B | 33.51B | 34.39B | 37.53B | 39.17B | 39.55B |
Total Debt | 15.07B | 15.28B | 15.87B | 17.95B | 19.25B | 19.89B |
Book Value | 52.77B | 47.9B | 38.83B | 36.91B | 36.02B | 33B |
Book Value Per Share | 30.21 | 27.40 | 22.20 | 20.92 | 20.14 | 18.48 |
Common Stock | 25.53B | 25.15B | 24.87B | 24.71B | 24.47B | 24.15B |
Retained Earnings | 49.78B | 47.26B | 37.55B | 35.26B | 31.53B | 27.63B |
Comprehensive Income | -6B | -7.91B | -7.84B | -8.05B | -8.37B | -8.95B |
Shareholders Equity | 52.13B | 47.66B | 38.6B | 36.69B | 35.8B | 32.78B |
Total Investments | 1.34B | 1.24B | 1.18B | 1.05B | 1.35B | 1.34B |
Add to Watchlist
Select watchlists to add or remove ABT